2.15
Schlusskurs vom Vortag:
$2.09
Offen:
$2.09
24-Stunden-Volumen:
186.29K
Relative Volume:
0.43
Marktkapitalisierung:
$5.10M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-11.28M
KGV:
-0.7143
EPS:
-3.01
Netto-Cashflow:
$-9.78M
1W Leistung:
+1.42%
1M Leistung:
-0.46%
6M Leistung:
-64.46%
1J Leistung:
-65.00%
Ensysce Biosciences Inc Stock (ENSC) Company Profile
Firmenname
Ensysce Biosciences Inc
Sektor
Branche
Telefon
(858) 263-4196
Adresse
7946 IVANHOE AVENUE, LA JOLLA
Vergleichen Sie ENSC mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
ENSC
Ensysce Biosciences Inc
|
2.15 | 4.93M | 0 | -11.28M | -9.78M | -3.01 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.42B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
![]()
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Ensysce Biosciences Inc Aktie (ENSC) Neueste Nachrichten
Novel Opioid with Built-in Overdose Protection Enters Final Testing Phase as Ensysce Secures Major Funding - Stock Titan
Can Ensysce Biosciences Inc. rally from current levelsEarnings Performance Report & Stepwise Entry and Exit Trade Signals - Newser
Published on: 2025-08-13 08:31:33 - Newser
Is Ensysce Biosciences Inc. stock reversal real or fake2025 Retail Activity & Verified Entry Point Signals - Newser
Automated trading signals detected on Ensysce Biosciences Inc.Market Trend Report & Weekly Top Stock Performers List - Newser
Identifying reversal signals in Ensysce Biosciences Inc.Rate Hike & Verified Chart Pattern Signals - Newser
Intraday pattern recognizer results for Ensysce Biosciences Inc.2025 Dividend Review & Community Consensus Trade Alerts - Newser
Combining price and volume data for Ensysce Biosciences Inc.Gap Up & Free Technical Confirmation Trade Alerts - Newser
Analyzing net buyer seller activity in Ensysce Biosciences Inc.July 2025 Big Picture & Smart Allocation Stock Tips - Newser
Backtesting results for Ensysce Biosciences Inc. trading strategiesBreakout Stock Opportunities with Low Drawdown - Newser
What technical models suggest about Ensysce Biosciences Inc.’s comebackAI-Powered Stock Trend Movement Analysis - Newser
What are the future prospects of Ensysce Biosciences Inc.Smart Entry Exit Suggestions - thegnnews.com
Volatility clustering patterns for Ensysce Biosciences Inc.Short-Term Profit Alert With Entry Forecast - Newser
ENSC SEC FilingsEnsysce Biosciences Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Ensysce Biosciences (ENSC) Projected to Post Quarterly Earnings on Wednesday - Defense World
Will breakout in Ensysce Biosciences Inc. lead to full recoveryFree Target Return Focused Trade Insights - Newser
Does Ensysce Biosciences Inc. show high probability of reboundPattern Recognition Based Market Move Prediction - Newser
Is Ensysce Biosciences Inc. stock poised for growthFree Early Entry Tips With Low Risk Zone - Newser
What Fibonacci levels say about Ensysce Biosciences Inc. reboundOversold Reversal Picks with Buy Zone - Newser
Real time alert setup for Ensysce Biosciences Inc. performanceFree Weekly Stock Watch With Growth Focus - Newser
Can volume confirm reversal in Ensysce Biosciences Inc.Predictable Return Plan with Entry Guidance - Newser
Ensysce Biosciences Inc. stock outlook for YEARTen-Year Sector Performance and Summary Analysis - Newser
Ensysce Biosciences Inc. stock momentum explainedDaily Pattern Analysis with Return Forecast - Newser
Ensysce Biosciences ENSC Q2 2025 Earnings Preview Downside Risk Amid Competitive Market Challenges - AInvest
Visualizing Ensysce Biosciences Inc. stock with heatmapsWeekly Breakout Forecast with Entry Zones - Newser
What MACD signals say about Ensysce Biosciences Inc.Safe and Scalable Return Strategy Blueprint - Newser
Is Ensysce Biosciences Inc. reversing from oversold territoryFree Oversold Recovery Opportunity Stocks - Newser
Why Ensysce Biosciences Inc. stock attracts strong analyst attentionHigh Return Trade Roadmap with Setup Filters - Newser
Ensysce Biosciences Inc expected to post a loss of $1.18 a shareEarnings Preview - TradingView
Earnings visualization tools for Ensysce Biosciences Inc.Free Smart Allocation Stock Pick Insights - Newser
How to manage a losing position in Ensysce Biosciences Inc.AI-Based Signal Detection for Active Traders - Newser
Finanzdaten der Ensysce Biosciences Inc-Aktie (ENSC)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):